MSTN and Duchenne muscular dystrophy: In addition, myostatin was significantly lower in nonambulant patients with DMD and BMD compared with patients who were still able to walk.16 However, given the progressive nature of diseases such as DMD and BMD, it is difficult to demonstrate a relationship between a biomarker and functional performance in cross-sectional studies, where age alone is often associated with functional decline.